2025/26 Taught Postgraduate Programme Catalogue

MSc Drug Discovery and Development

Programme overview

Programme code
MSC-BSGS/DDD
UCAS code
Duration
12 Months
Method of Attendance
Full Time
Programme manager
Dr Dan Donnelly
Contact address
D.Donnelly@leeds.ac.uk
Total credits
180
School/Unit responsible for the parenting of students and programme
Biomedical Sciences, Faculty of Biological Sciences
Examination board through which the programme will be considered
Masters Taught Student Education Examination Board
Relevant QAA Subject Benchmark Groups
Students will be expected to demonstrate the characteristics embodied in the QAA Qualifications Frameworks level descriptors for Masters degrees (https://www.qaa.ac.uk/docs/qaa/quality-code/master's-degree-characteristics-statement.pdf).

Entry requirements

Entry Requirements are available on the Course Search entry

Programme specification

The programme will provide an integrated understanding of the pathways of drug discovery, development and exploitation and will highlight the interdisciplinary and 'problem-based' nature of research in this area. Students with a range of relevant undergraduate backgrounds (e.g. chemistry/pharmacology/biochemistry/pharmaceutical science/biomedical science) will be recruited.

The programme’s material will cover the key techniques and methodology used in medicinal chemistry and pharmacology to discover and develop new drugs for therapeutic use. After introducing the pharmaceutical business sector from the scientific and commercial perspectives, the programme covers the main scientific background disciplines at undergraduate foundation level in order to ensure the diverse intake of students have studied the key disciplines (organic chemistry, biochemistry, pharmacology, etc.) they may have missed in their particular undergraduate programme. There are then two further key semester 1 modules that cover modern drug discovery as well as research planning & communication, providing students with a deeper understanding of core elements of drug discovery alongside training in high level research skills. Additional semester 1 and 2 modules focus on more specialist areas and the acquisition of the technical skills necessary for drug discovery and development. Dependent on the students’ background and interests, these optional modules include advanced topics in chemistry, practical recombinant DNA technology, animal models, cancer drug development, structure-based drug discovery, and clinical pharmacology and human trials. The course material will be reinforced through deductive problems and student-led activities allowing students to exploit a diverse range of skills, to appreciate the advantages and limitations of each research approach, and to be prepared for the necessarily inquisitive nature of research. The approach is highly interdisciplinary, and will equip students to work in such broad-based teams.

Students will cap their Masters programme by undertaking a 60 credit extended research project supervised by research-active academic staff and it is expected that a large proportion of the projects will be interdisciplinary. The world class research facilities and the range of expertise at Leeds means that students will be able to select the research approaches which are most suited to the biological/medicinal chemistry problem in hand. The initial report will require students to appreciate the background to the research problem, to formulate hypotheses, to propose a programme of work and to explain which of the proposed approaches is best suited to address the underlying research problem. The research work will be conducted within the vigorous research atmosphere fostered by the wide range of medicinal chemistry, structural molecular biology and drug-related research at the University of Leeds.

Last updated: 30/04/2025 16:00:36

Errors, omissions, failed links etc should be notified to the Catalogue Team